STOCKHOLM, March 1,
2024 /PRNewswire/ -- Calliditas Therapeutics AB
(Nasdaq: CALT) and (Nasdaq Stockholm: CALTX) ("Calliditas"), a
commercial biopharma company focused on rare diseases today
announced that Renee
Aguiar-Lucander, CEO of Calliditas will participate in the
following March 2024 conferences.
Carnegie Healthcare Seminar, Wednesday, March 6, 2024. Fireside chat
will be held at 10:20 - 10:50 am CET
and one-on-one meetings will be available.
Jefferies Biotech on the Bay Summit, Wednesday, March 13, 2024 in Miami, FL, one-on-one meetings will be
available.
Leerink Partners Global Biopharma Conference on
March 12, 2024 in Miami, FL.
For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com
The information was sent for publication, through the agency
of the contact person set out above, on March 1, 2024, at 13:00
CET.
The following files are available for download:
https://mb.cision.com/Main/16574/3939155/2640916.pdf
|
PM_March
Events_ENG
|
View original
content:https://www.prnewswire.com/news-releases/calliditas-therapeutics-to-attend-investor-conferences-in-march-302077149.html
SOURCE Calliditas Therapeutics